{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:04:58Z","timestamp":1789693498598,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T00:00:00Z","timestamp":1785628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cellsig.2026.112770","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:56:01Z","timestamp":1785455761000},"page":"112770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Network pharmacology and experimental validation reveal the therapeutic effect and chemosensitization mechanism of brusatol against oral squamous cell carcinoma"],"prefix":"10.1016","volume":"148","author":[{"given":"Danfeng","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingkun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangliang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2026.112770_bb0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13073-018-0569-7","article-title":"Functional and genomic analyses reveal therapeutic potential of targeting \u03b2-catenin\/CBP activity in head and neck cancer","volume":"10","author":"Kartha","year":"2018","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112770_bb0010","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2026.112770_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.761379","article-title":"The molecular basis and therapeutic aspects of cisplatin resistance in Oral squamous cell carcinoma","volume":"11","author":"Cheng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112770_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-4598-11-33","article-title":"Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis","volume":"11","author":"Sun","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112770_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biopha.2018.12.010","article-title":"Phytochemicals: current strategy to sensitize cancer cells to cisplatin","volume":"110","author":"Sun","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112770_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217116","article-title":"Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment","volume":"598","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112770_bb0035","first-page":"359","article-title":"Brusatol: A potential anti-tumor quassinoid from Brucea javanica","volume":"12","author":"Yu","year":"2020","journal-title":"Chin. Herb Med."},{"key":"10.1016\/j.cellsig.2026.112770_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114134","article-title":"Brusatol: a potential sensitizing agent for cancer therapy from Brucea javanica","volume":"158","author":"He","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112770_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156912","article-title":"Brusatol induced ferroptosis in osteosarcoma cells by modulating the Keap1\/Nrf2\/SLC7A11 signaling pathway","volume":"144","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"issue":"14","key":"10.1016\/j.cellsig.2026.112770_bb0050","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.7150\/thno.20861","article-title":"Brusatol-mediated inhibition of c-Myc increases HIF-1\u03b1 degradation and causes cell death in colorectal Cancer under hypoxia","volume":"7","author":"Oh","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2026.112770_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106059","article-title":"Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis","volume":"176","author":"Xing","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellsig.2026.112770_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jare.2020.07.004","article-title":"Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"26","author":"Lee","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.cellsig.2026.112770_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13578-019-0309-8","article-title":"Brusatol, an NRF2 inhibitor for future cancer therapeutic","volume":"9","author":"Cai","year":"2019","journal-title":"Cell Biosci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112770_bb0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/jpp\/rgab018","article-title":"An in vitro study on the reversal of epithelial to mesenchymal transition by brusatol and its synergistic properties in triple-negative breast cancer cells","volume":"73","author":"Chandrasekaran","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112770_bb0075","article-title":"Targeting NRF2 sensitizes esophageal adenocarcinoma cells to cisplatin through induction of ferroptosis and apoptosis","volume":"11","author":"Ballout","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112770_bb0080","article-title":"Dexamethasone sensitizes Cancer stem cells to gemcitabine and 5-fluorouracil by increasing reactive oxygen species production through NRF2 reduction","volume":"11","author":"Suzuki","year":"2021","journal-title":"Life (Basel)"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112770_bb0085","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41419-019-2081-4","article-title":"Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells","volume":"10","author":"Kleih","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112770_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105732","article-title":"ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells","volume":"122","author":"Xue","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112770_bb0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccell.2017.09.008","article-title":"iASPP is an antioxidative factor and drives Cancer growth and drug resistance by competing with Nrf2 for Keap1 binding","volume":"32","author":"Ge","year":"2017","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112770_bb0100","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.ymthe.2024.08.019","article-title":"Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8(+) T and CAR-T cells","volume":"32","author":"Jo","year":"2024","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112770_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2026.112770_bb0110","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fonc.2019.00754","article-title":"SIRT5 promotes cisplatin resistance in ovarian Cancer by suppressing DNA damage in a ROS-dependent manner via regulation of the Nrf2\/HO-1 pathway","volume":"9","author":"Sun","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112770_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110676","article-title":"Emerging role of NRF2 in ROS-mediated tumor chemoresistance","volume":"131","author":"Xue","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"Pt 6","key":"10.1016\/j.cellsig.2026.112770_bb0120","article-title":"Elucidation of the anti-colon cancer mechanism of Phellinus baumii polyphenol by an integrative approach of network pharmacology and experimental verification","volume":"253","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112770_bb0125","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.7150\/thno.37556","article-title":"Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112770_bb0130","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1158\/1078-0432.CCR-18-2739","article-title":"Long noncoding RNA MPRL promotes mitochondrial fission and cisplatin chemosensitivity via disruption of pre-miRNA processing","volume":"25","author":"Tian","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112770_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112770_bb0140","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7150\/thno.87329","article-title":"Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma via miR-876-3p","volume":"14","author":"Kang","year":"2024","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112770_bb0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/acsbiomaterials.7b00921","article-title":"Platinum (II) complex-nuclear localization sequence peptide hybrid for overcoming platinum resistance in cancer therapy","volume":"4","author":"Wlodarczyk","year":"2018","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.cellsig.2026.112770_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107788","article-title":"Targeting tumor-associated macrophage polarization with traditional Chinese medicine active ingredients: dual reversal of chemoresistance and immunosuppression in tumor microenvironment","volume":"216","author":"Qi","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112770_bb0155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jpp\/rgae017","article-title":"Brusatol's anticancer activity and its molecular mechanism: a research update","volume":"76","author":"Xi","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112770_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.11.001","article-title":"Modulating ROS to overcome multidrug resistance in cancer","volume":"41","author":"Cui","year":"2018","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112770_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-021-04285-3","article-title":"Glaucocalyxin a induces apoptosis and autophagy in tongue squamous cell carcinoma cells by regulating ROS","volume":"88","author":"Shi","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112770_bb0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jpp\/rgaa027","article-title":"Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma","volume":"73","author":"Xue","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112770_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5649174","article-title":"Plumbagin enhances the anticancer efficacy of cisplatin by increasing intracellular ROS in human tongue squamous cell carcinoma","volume":"2020","author":"Xue","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112770_bb0180","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.1014275108","article-title":"Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism","volume":"108","author":"Ren","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2026.112770_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157142","article-title":"Brusatol suppresses malignant progression of glioma via modulating the miR-574-5p\/USP10\/PLK1 axis","volume":"146","author":"Ma","year":"2025","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112770_bb0190","first-page":"1447","article-title":"Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells","volume":"41","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cellsig.2026.112770_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111652","article-title":"Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C","volume":"142","author":"Cheng","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112770_bb0200","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7150\/ijbs.85443","article-title":"Promotion of ROS-mediated apoptosis, G2\/M arrest, and autophagy by naringenin in non-small cell lung cancer","volume":"20","author":"Chang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2026.112770_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107664","article-title":"NRF2 in human neoplasm: Cancer biology and potential therapeutic target","volume":"217","author":"Liu","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cellsig.2026.112770_bb0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2020.02.021","article-title":"Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism","volume":"150","author":"Cucci","year":"2020","journal-title":"Free Radic. Biol. Med."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826004274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:17:58Z","timestamp":1789690678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826004274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S0898656826004274"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112770","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network pharmacology and experimental validation reveal the therapeutic effect and chemosensitization mechanism of brusatol against oral squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112770"}}